HeartWare International Stock Price, News & Analysis (NASDAQ:HTWR)

$58.20 0.22 (0.38 %)
(As of 12/18/2017 03:57 AM ET)
Previous Close$57.98
Today's Range$58.20 - $58.20
52-Week Range$25.01 - $87.38
Volume762 shs
Average Volume528,597 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About HeartWare International (NASDAQ:HTWR)

HeartWare International logoHeartware International, Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The Company operates in the segment of design and manufacture of medical devices. The HeartWare Ventricular Assist System (HVAD System), which includes a ventricular assist device (VAD) or blood pump, patient accessories and surgical tools, provides circulatory support for patients in the advanced stage of heart failure. The HVAD System is designed to be implanted adjacent to the heart, avoiding abdominal surgery. The HVAD System features the centrifugal pump designed to be implanted in the chest, directly adjacent to the heart. It develops MVAD System, a miniaturized device. The CircuLite Surgical System is designed to be implanted through a right, mini-thoracotomy procedure and does not require a sternotomy or cardiopulmonary bypass.

Receive HTWR News and Ratings via Email

Sign-up to receive the latest news and ratings for HTWR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices & Implants
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNASDAQ:HTWR
CUSIP42236810
Phone+1-508-7390873

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($3.40)
Net IncomeN/A
Net Margins-15.84%
Return on Equity-25.32%
Return on Assets-10.14%

Miscellaneous

EmployeesN/A
Outstanding Shares17,560,000

HeartWare International (NASDAQ:HTWR) Frequently Asked Questions

What is HeartWare International's stock symbol?

HeartWare International trades on the NASDAQ under the ticker symbol "HTWR."

How were HeartWare International's earnings last quarter?

HeartWare International Inc (NASDAQ:HTWR) released its quarterly earnings data on Thursday, July, 28th. The medical instruments supplier reported ($0.43) earnings per share for the quarter, beating analysts' consensus estimates of ($0.82) by $0.39. The medical instruments supplier had revenue of $68.72 million for the quarter, compared to analyst estimates of $57.36 million. HeartWare International had a negative net margin of 15.84% and a negative return on equity of 25.32%. The business's quarterly revenue was down 6.6% compared to the same quarter last year. During the same period last year, the firm earned ($0.47) earnings per share. View HeartWare International's Earnings History.

Who are some of HeartWare International's key competitors?

How do I buy HeartWare International stock?

Shares of HeartWare International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HeartWare International's stock price today?

One share of HeartWare International stock can currently be purchased for approximately $58.20.

How can I contact HeartWare International?

HeartWare International's mailing address is 500 Old Connecticut Path, FRAMINGHAM, MA 1701, United States. The medical instruments supplier can be reached via phone at +1-508-7390873.


MarketBeat Community Rating for HeartWare International (HTWR)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  364 (Vote Outperform)
Underperform Votes:  289 (Vote Underperform)
Total Votes:  653
MarketBeat's community ratings are surveys of what our community members think about HeartWare International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

HeartWare International (NASDAQ:HTWR) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.142.132.222.21
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
11 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $58.00$58.00$53.17$49.78
Price Target Upside: 0.03% upside0.03% upside8.30% downside14.15% downside

HeartWare International (NASDAQ:HTWR) Consensus Price Target History

Price Target History for HeartWare International (NASDAQ:HTWR)

HeartWare International (NASDAQ:HTWR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/25/2016BTIG ResearchReiterated RatingHoldN/AView Rating Details
7/28/2016Canaccord GenuityReiterated RatingBuy$58.00N/AView Rating Details
7/13/2016Raymond James FinancialDowngradeOutperform -> Market PerformN/AView Rating Details
7/11/2016Leerink SwannDowngradeOutperform -> Market Perform$58.00N/AView Rating Details
6/29/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
6/29/2016BarclaysDowngradeOverweight -> Equal Weight$35.00 -> $58.00N/AView Rating Details
6/28/2016SunTrust BanksDowngradeBuy -> Neutral$60.00 -> $58.00N/AView Rating Details
6/8/2016GuggenheimInitiated CoverageNeutralN/AView Rating Details
4/25/2016Bank of AmericaReiterated RatingBuyN/AView Rating Details
2/27/2016Northland SecuritiesReiterated RatingHoldN/AView Rating Details
1/31/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
1/13/2016OppenheimerReiterated RatingMarket PerformN/AView Rating Details
1/12/2016Sterne Agee CRTReiterated RatingBuy$60.00 -> $55.00N/AView Rating Details
1/12/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$56.00 -> $39.00N/AView Rating Details
(Data available from 12/18/2015 forward)

Earnings

HeartWare International (NASDAQ:HTWR) Earnings History and Estimates Chart

Earnings by Quarter for HeartWare International (NASDAQ:HTWR)

HeartWare International (NASDAQ HTWR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q2($0.82)($0.43)$57.36 million$68.72 millionViewN/AView Earnings Details
5/4/2016Q116($0.79)($0.95)$60.07 million$55.10 millionViewListenView Earnings Details
2/25/2016Q415($0.74)($0.53)$67.87 million$68.10 millionViewListenView Earnings Details
10/29/2015Q315($0.53)($1.36)$67.54 million$65.20 millionViewListenView Earnings Details
7/30/2015Q215($0.49)($0.47)$72.08 million$73.60 millionViewListenView Earnings Details
4/30/2015Q115($0.57)($0.55)$73.38 million$70.00 millionViewListenView Earnings Details
2/26/2015Q414($0.55)($0.41)$72.10 million$72.20 millionViewListenView Earnings Details
10/30/2014Q3($0.66)($0.64)$69.30 million$68.60 millionViewListenView Earnings Details
7/31/2014Q2($0.71)($0.29)$67.01 million$70.10 millionViewListenView Earnings Details
5/1/2014Q1($0.86)($0.70)$59.03 million$66.47 millionViewListenView Earnings Details
2/27/2014Q4($0.79)($0.92)$55.92 million$53.10 millionViewListenView Earnings Details
8/8/2013Q2 2013($0.73)($0.79)ViewListenView Earnings Details
2/27/2013Q4 2012($1.64)($1.46)$30.92 million$32.66 millionViewListenView Earnings Details
11/9/2012Q312($1.54)($1.75)$26.09 million$22.90 millionViewN/AView Earnings Details
8/4/2011($0.62)($0.73)ViewN/AView Earnings Details
5/5/2011($0.62)($0.68)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

HeartWare International (NASDAQ:HTWR) Earnings Estimates

2017 EPS Consensus Estimate: ($2.51)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172($0.75)($0.40)($0.58)
Q2 20171($0.79)($0.79)($0.79)
Q3 20172($0.71)($0.42)($0.57)
Q4 20171($0.58)($0.58)($0.58)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for HeartWare International (NASDAQ:HTWR)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

HeartWare International (NASDAQ HTWR) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for HeartWare International (NASDAQ:HTWR)
Institutional Ownership by Quarter for HeartWare International (NASDAQ:HTWR)

HeartWare International (NASDAQ HTWR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/22/2016Mark StrongVPSell1,875$57.71$108,206.25View SEC Filing  
7/11/2016Peter F McareeCFOSell3,125$57.68$180,250.00View SEC Filing  
7/1/2016James SchuermannSVPSell1,000$57.77$57,770.00View SEC Filing  
4/1/2016James SchuermannSVPSell1,000$31.36$31,360.00View SEC Filing  
2/29/2016Stephen N OesterleDirectorBuy1,000$32.17$32,170.00View SEC Filing  
2/25/2016Douglas Evan GodshallInsiderSell1,990$29.20$58,108.00View SEC Filing  
2/25/2016James SchuermannSVPSell601$29.24$17,573.24View SEC Filing  
2/25/2016Lawrence J KnopfGeneral CounselSell423$29.16$12,334.68View SEC Filing  
2/25/2016Mark StrongVPSell395$29.68$11,723.60View SEC Filing  
2/25/2016Peter F McareeCFOSell697$29.01$20,219.97View SEC Filing  
2/24/2016Douglas Evan GodshallInsiderSell1,153$32.35$37,299.55View SEC Filing  
2/24/2016Lawrence J KnopfGeneral CounselSell287$32.27$9,261.49View SEC Filing  
2/24/2016Mark StrongVPSell750$32.34$24,255.00View SEC Filing  
2/24/2016Peter F McareeCFOSell438$32.38$14,182.44View SEC Filing  
2/8/2016Douglas Evan GodshallinsiderSell1,796$36.58$65,697.68View SEC Filing  
2/8/2016James SchuermannSVPSell647$36.77$23,790.19View SEC Filing  
2/8/2016Lawrence J. KnopfGeneral CounselSell568$36.49$20,726.32View SEC Filing  
2/8/2016Peter F. McareeCFOSell700$36.85$25,795.00View SEC Filing  
12/22/2015Douglas Evan GodshallinsiderSell4,324$46.30$200,201.20View SEC Filing  
12/22/2015James SchuermannSVPSell1,202$46.39$55,760.78View SEC Filing  
12/22/2015Lawrence J. KnopfGeneral CounselSell721$46.44$33,483.24View SEC Filing  
12/21/2015James SchuermannSVPSell553$46.54$25,736.62View SEC Filing  
10/1/2015James SchuermannSVPSell1,000$53.01$53,010.00View SEC Filing  
10/1/2015Mark StrongVPSell2,625$52.55$137,943.75View SEC Filing  
8/26/2015Katrin LeadleyinsiderSell3,750$80.02$300,075.00View SEC Filing  
7/22/2015Mark StrongVPSell1,875$88.06$165,112.50View SEC Filing  
7/10/2015Peter F McareeCFOSell3,125$73.36$229,250.00View SEC Filing  
7/1/2015James SchuermannSVPSell1,000$72.78$72,780.00View SEC Filing  
4/21/2015Adage Capital Partners Gp LlcMajor ShareholderSell173,267$80.70$13,982,646.90View SEC Filing  
4/1/2015James SchuermannSVPSell1,000$86.34$86,340.00View SEC Filing  
3/30/2015Lawrence J KnopfGeneral CounselSell1,741$88.81$154,618.21View SEC Filing  
2/25/2015Douglas Evan GodshallInsiderSell1,842$89.58$165,006.36View SEC Filing  
2/9/2015Douglas Evan GodshallInsiderSell1,698$86.58$147,012.84View SEC Filing  
1/2/2015James SchuermannSVPSell1,429$72.69$103,874.01View SEC Filing  
12/22/2014James SchuermannSVPSell2,421$73.00$176,733.00View SEC Filing  
12/22/2014Jeffrey LaroseInsiderSell3,072$72.98$224,194.56View SEC Filing  
12/1/2014James SchuermannSVPSell1,500$73.06$109,590.00View SEC Filing  
11/3/2014James SchuermannSVPSell1,500$76.36$114,540.00View SEC Filing  
10/1/2014Mark StrongVPSell2,625$76.96$202,020.00View SEC Filing  
9/15/2014Adage Capital Partners Gp LlcMajor ShareholderBuy100,000$76.94$7,694,000.00View SEC Filing  
9/15/2014Jeffrey LaroseInsiderBuy150$77.11$11,566.50View SEC Filing  
8/19/2014Jeffrey LaroseInsiderSell2,179$81.51$177,610.29View SEC Filing  
8/18/2014Robert Bain ThomasDirectorSell1,000$81.97$81,970.00View SEC Filing  
7/10/2014Peter F McareeCFOSell2,070$84.76$175,453.20View SEC Filing  
5/19/2014Robert Bain ThomasDirectorSell1,000$93.39$93,390.00View SEC Filing  
5/14/2014Robert Bain ThomasDirectorSell1,000$93.16$93,160.00View SEC Filing  
5/7/2014Robert Bain ThomasDirectorSell2,000$93.70$187,400.00View SEC Filing  
5/1/2014Jeffrey LaroseInsiderSell2,179$89.96$196,022.84View SEC Filing  
4/1/2014Jeffrey LaroseInsiderSell2,179$94.26$205,392.54View SEC Filing  
3/31/2014Lawrence KnopfGeneral CounselSell1,744$91.15$158,965.60View SEC Filing  
3/11/2014David HathawayInsiderSell4,413$95.00$419,235.00View SEC Filing  
3/3/2014Jeffrey LaroseInsiderSell2,179$93.15$202,973.85View SEC Filing  
2/10/2014Douglas Evan GodshallInsiderSell2,428$94.57$229,615.96View SEC Filing  
2/3/2014Jeffrey LaroseInsiderSell2,179$98.48$214,587.92View SEC Filing  
1/7/2014Jeffrey LaroseInsiderSell15,342$100.00$1,534,200.00View SEC Filing  
1/6/2014Seth Loring HarrisonDirectorSell7,909$99.29$785,284.61View SEC Filing  
1/2/2014Jeffrey LaroseInsiderSell2,179$92.82$202,254.78View SEC Filing  
12/23/2013Douglas Evan GodshallInsiderSell7,036$91.37$642,879.32View SEC Filing  
12/23/2013James SchuermannSVPSell2,609$91.41$238,488.69View SEC Filing  
12/4/2013Robert Bain ThomasDirectorSell2,500$95.54$238,850.00View SEC Filing  
12/2/2013Douglas Evan GodshallInsiderSell13,000$95.51$1,241,630.00View SEC Filing  
11/7/2013Douglas Evan GodshallInsiderSell8,000$83.06$664,480.00View SEC Filing  
10/14/2013Douglas Evan GodshallInsiderSell8,000$75.03$600,240.00View SEC Filing  
9/3/2013Douglas Evan GodshallInsiderSell8,000$78.08$624,640.00View SEC Filing  
8/1/2013James SchuermannSVPSell1,000$93.07$93,070.00View SEC Filing  
8/1/2013Jeffrey LaroseInsiderSell2,179$93.11$202,886.69View SEC Filing  
7/29/2013Douglas Evan GodshallInsiderSell33,000$92.95$3,067,350.00View SEC Filing  
7/10/2013Peter F McareeCFOSell2,950$93.58$276,061.00View SEC Filing  
7/1/2013Jeffrey LaroseInsiderSell2,179$95.85$208,857.15View SEC Filing  
7/1/2013Seth Loring HarrisonDirectorSell13,118$95.57$1,253,687.26View SEC Filing  
6/25/2013Robert E YocherSVPSell1,162$94.25$109,518.50View SEC Filing  
6/17/2013Jeffrey LaroseInsiderSell2,179$91.14$198,594.06View SEC Filing  
6/6/2013Robert Bain ThomasDirectorSell2,656$90.44$240,208.64View SEC Filing  
5/30/2013Robert Bain ThomasDirectorSell3,557$94.04$334,500.28View SEC Filing  
5/28/2013David R HathawayInsiderSell5,934$95.05$564,026.70View SEC Filing  
5/22/2013David R HathawayInsiderSell29,540$96.38$2,847,065.20View SEC Filing  
5/20/2013Denis Newell WadeDirectorSell4,000$99.00$396,000.00View SEC Filing  
5/20/2013Jeffrey LaroseInsiderSell9,574$97.79$936,241.46View SEC Filing  
5/20/2013Lawrence J KnopfGeneral CounselSell2,000$97.72$195,440.00View SEC Filing  
12/4/2012Robert Bain ThomasDirectorSell5,000$80.43$402,150.00View SEC Filing  
11/1/2012James SchuermannSVPSell1,000$84.01$84,010.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

HeartWare International (NASDAQ HTWR) News Headlines

Source:

SEC Filings

HeartWare International (NASDAQ:HTWR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

HeartWare International (NASDAQ:HTWR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

HeartWare International (NASDAQ HTWR) Stock Chart for Monday, December, 18, 2017

Loading chart…

This page was last updated on 12/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.